| Date Filed | Type | Description |
| 02/28/2018 |
4
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Sold 1,500,000 shares
@ $0.55, valued at
$825k
Sold 41,331 shares
@ $0.53, valued at
$21.9k
|
|
| 02/13/2018 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 5.5% stake in LIPOCINE INC. |
| 02/13/2018 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 2.9% stake in BioCryst Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 17.4% stake in ARCA biopharma, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 03/03/2016 |
SC 13G
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 9.1% stake in Ocera Therapeutics, Inc. |
| 02/16/2016 |
SC 13G/A
| MARATHON BAR CORP reports a 7% stake in LIPOCINE INC. |
| 02/16/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2016 |
SC 13G/A
| ALCOBRA LTD. reports a 5.9% stake in ALCOBRA LTD. |
| 02/16/2016 |
SC 13G
| ReGenX Biosciences, LLC reports a 4.1% stake in REGENXBIO INC. |
| 08/07/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/19/2013 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 03/19/2013 |
4
| VHCP Co-Investment Holdings, LLC (10% Owner) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Disposed of 504,255 shares
@ $0
Disposed of 95,745 shares
@ $0
Acquired 88,262 shares
@ $0
Acquired 7,483 shares
@ $0
Acquired 18,910 shares
@ $0 |
|
| 09/24/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 19,273 shares
@ $6.3019, valued at
$121.5k
|
|
| 09/18/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc |
| 09/13/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 10,177 shares
@ $6.6427, valued at
$67.6k
Sold 15,000 shares
@ $6.5553, valued at
$98.3k
|
|
| 07/06/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 07/05/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Disposed of 900,000 shares
@ $0
Acquired 79,450 shares
@ $0 |
|
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/04/2011 |
4
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Bought 75,000 shares
@ $4.9999, valued at
$375k
|
|
| 02/04/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 09/22/2010 |
4
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Sold 83,691 shares
@ $6.2995, valued at
$527.2k
Sold 15,309 shares
@ $6.2995, valued at
$96.4k
|
|
| 07/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 07/12/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/15/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/02/2010 |
3
| VENROCK ASSOCIATES (10% Owner) has filed a Form 3 on IRONWOOD PHARMACEUTICALS INC |
| 01/05/2010 |
SC 13G
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a |
| 01/04/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |